Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Just Relax

<< Previous

Bullboard Posts

Next >>

Comment by mstrmndon Jun 18, 2020 12:50am

87 Views

Post# 31163363

RE:RE:RE:Just Relax

Hey lady, awww, something wrong? You need a man to hug?

AlbertaGuy9 wrote: Hey Mentalmind where were you since morning? Crying in ur basement? Talk to your Lawyer..

mstrmnd wrote: Some of us are just here for sh*ts and giggles. Man this ride is going to be so fun. The medical is legit. I think that Albertagal said $8 a share or something. Doesn't matter, the excitement is going to be worth every penny!

Jefnan1 wrote: I have over 5 million shares at .15 since 2014. I suggest you people just relax and wait and you should end up on the good side of your investments